Where does Adagio Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Adagio Medical, Inc. ranks #17,406 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Adagio Medical, Inc. hold?

Adagio Medical, Inc. holds 16 US utility patents granted between 2016 and 2025, spanning 2 technology areas.

What is Adagio Medical, Inc.'s Innovation Score?

Adagio Medical, Inc. has an Innovation Score of 28.3 out of 100 (27th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Adagio Medical, Inc. focus on?

Adagio Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 16 patents, ranking #1,103 of 7,127 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Adagio Medical, Inc.'s patent grant rate increasing or decreasing?

Adagio Medical, Inc.'s recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Adagio Medical, Inc.'s patents?

Adagio Medical, Inc.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Adagio Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Adagio Medical, Inc.

USPTO PatentsView assignee record - 16 granted patents across 2 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Adagio ranks #17,406 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 2 technology areas.

#17,406
of 49,997 US assignees by volume: 27th percentile
by Innovation Score (28.3/100): 16.9
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17406 · US Corporation #17,406 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,406/49,997
PHOTO-FINISH Accelerated…
CPC-NARROW A61B · 2 areas
INNOV-THIN 28.3/100
CLAIMS-RICH 16.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Accelerated Biosciences Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Adagio’s 28.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (35%) Velocity 3.3 pts (12%) Breadth 5.0 pts (18%) Claim depth 10.2 pts (36%)

Qualcomm Incorporated · highest

85
Adagio Medical · this assignee

28
3D Lighting… · lowest

7

What this shows Adagio's Innovation Score is 28.3/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Adagio?

Each dot is one of Adagio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adagio’s own 16.9 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Adagio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Adagio's grants concentrate

Adagio Medical, Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2016. By volume, Adagio sits between Autonomic Technologies, Inc. and Aerco International, Inc..

Adagio's three-year grant acceleration

Adagio Medical, Inc. shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Autonomic

16
Avita

16
Accelerated Biosc…

16
Acell Industries

16
Adeia Media Solut…

16
Adler Pelzer Hold…

16
Advanced Accelera…

16
Aerco Internation…

16
Adagio Medical ◀

16

What this shows Adagio holds 16 patents at rank #17,435, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Adagio

By rank, the assignees closest to #17,435 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Adagio's primary technology class.

Adagio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Adagio Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.3%
2018	1	6.3%
2020	4	25.0%
2021	4	25.0%
2023	2	12.5%
2024	2	12.5%
2025partial year	2	12.5%

Which technologies does Adagio Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 16

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Adagio Medical, Inc.'s patent record in context - here's where to go next.

Adagio Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #17,406 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Adagio Medical, Inc. against Autonomic Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.